Related Experiment Video
Updated: Jul 14, 2026

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver
1Lawrence Ellison Center for Tissue Regeneration and Repair, Department of Biochemistry and Molecular Medicine, University of California, Davis, Sacramento, CA 95817, USA.
Abstract:
Deleted in liver cancer 1 (DLC-1), as its name implied, was originally isolated as a potential tumor suppressor gene often deleted in hepatocellular carcinoma. Further studies have indicated that down-expression of DLC-1 either by genomic deletion or DNA methylation is associated with a variety of cancer types including lung, breast, prostate, kidney, colon, uterus, ovary, and stomach. Re-expression of DLC-1 in cancer cells regulates the structure of actin cytoskeleton and focal adhesions and significantly inhibits cell growth, supporting its role as a tumor suppressor. This tumor suppressive function relies on DLC-1's RhoGTPase activating protein (RhoGAP) activity and steroidogenic acute regulatory (StAR)-related lipid transfer (START) domain, as well as its focal adhesion localization, which is recruited by the Src Homology 2 (SH2) domains of tensins in a phosphotyrosine-independent fashion. Therefore, the expression and subcellular localization of DLC-1 could be a useful molecular marker for cancer prognosis, whereas DLC-1 and its downstream signaling molecules might be therapeutic targets for the treatment of cancer.
Insights
Deleted in liver cancer 1 (DLC-1) functions as a tumor suppressor gene, frequently lost in various cancers. Restoring DLC-1 inhibits cancer cell growth, highlighting its therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Deleted in liver cancer 1 (DLC-1) was identified as a tumor suppressor gene, often deleted in hepatocellular carcinoma.
- Down-expression of DLC-1, via genomic deletion or DNA methylation, is linked to numerous cancers (lung, breast, prostate, etc.).
Purpose of the Study:
- To elucidate the tumor suppressive role and molecular mechanisms of DLC-1.
- To evaluate DLC-1 as a potential biomarker and therapeutic target in cancer.
Main Methods:
- Analysis of DLC-1 expression patterns in various cancer types.
- Investigating the functional domains (RhoGAP, START) and localization of DLC-1.
- Assessing the impact of DLC-1 re-expression on cancer cell behavior.
Main Results:
- DLC-1 re-expression in cancer cells modulates actin cytoskeleton and focal adhesions, inhibiting cell proliferation.
- DLC-1's tumor suppressive activity depends on its RhoGAP and START domains and focal adhesion localization.
- DLC-1 localization is mediated by tensin SH2 domains in a phosphotyrosine-independent manner.
Conclusions:
- DLC-1 functions as a critical tumor suppressor across multiple cancer types.
- DLC-1 expression and localization serve as potential prognostic markers.
- DLC-1 and its downstream pathways represent promising therapeutic targets for cancer treatment.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
lncRNA - Long Non-coding RNAs

